Anti-Galectin-2 antibody treatment reduces atherosclerotic plaque size and alters macrophage polarity.
Sign Up to like & getrecommendations! Published in 2021 at "Thrombosis and haemostasis"
DOI: 10.1055/a-1711-1055
Abstract: Galectins have numerous cellular functions in immunity and inflammation. Short-term galectin-2 blockade in ischaemia-induced arteriogenesis shifts macrophages to an anti-inflammatory phenotype and improves perfusion. Galectin-2 may also affect other macrophage related cardiovascular diseases. This study… read more here.
Keywords: galectin; atherosclerosis; treatment; plaque size ... See more keywords
Relation between pre-existing plaque size and neointimal healing in an adult porcine model of familial hypercholesterolemia
Sign Up to like & getrecommendations! Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.2542
Abstract: Despite the efficacy of novel drug eluting stents (DES) in preventing restenosis, this complication still occurs, as do neo-atherosclerosis development and poor stent strut coverage that are associated with stent thrombosis. Safety and efficacy of… read more here.
Keywords: pre existing; response; plaque size; size ... See more keywords
Small plaque size variant of chikungunya primary isolate showed reduced virulence in mice.
Sign Up to like & getrecommendations! Published in 2018 at "Asian Pacific journal of allergy and immunology"
DOI: 10.12932/ap-250417-0079
Abstract: BACKGROUND Plaque size is a common feature of viral characterization. Small plaque size is used as a marker of attenuation for live-attenuated vaccine development. OBJECTIVE To investigate whether the naturally occurring plaque size variation reflects… read more here.
Keywords: plaque size; small plaque; plaque; virus ... See more keywords